Topic: How To Invest

Hi Pat: I would appreciate hearing from you about Verisante Technology. Thanks.

Article Excerpt

Verisante Technology Inc., $0.47, symbol VRS on Toronto (Shares outstanding: 53.5 million; Market cap: $25.1 million; www.verisante.com), is developing two products that it believes can help doctors detect cancer earlier: the Verisante Aura, for skin cancer detection, and the Verisante Core, for lung, colon and cervical cancer detection. The company is currently focused on the Verisante Aura, which it believes would eliminate many unnecessary biopsies. It designed this device to scan suspicious skin lesions for 21 different indicators of cancer and provide immediate, accurate results. Verisante held cash of $5.8 million on December 31, 2011. It is spending about $4 million a year to research and develop its devices, so it has the funds it needs for a year or more. As well, the company has attained Health Canada approval to sell the Verisante Aura, although it’s just beginning the approval process in the U.S. The market for devices that could provide early cancer detection more easily and with less cost than traditional methods…